Safety and recovery of rocuronium and sugammadex versus cisatracurium or atracurium and pyridostigmine in surgical patients with chronic kidney disease: a multicenter retrospective propensity score-matched study
Anesthesia and Pain Medicine · 31.10.2026 · 21 (4) · 553-566
DOI: 10.17085/apm.25496 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anesthesia and Pain Medicine, erschienen am 31.10.2026. Verfasst von Doyeop Lee und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology and Pain Medicine, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Korea. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Rocuronium and sugammadex are used cautiously in patients with chronic kidney disease (CKD) undergoing anesthesia because of delayed excretion. This multicenter retrospective study explored the safety and recovery of rocuronium–sugammadex compared to cisatracurium/atracurium–pyridostigmine in patients with CKD.
Methods
Patients with CKD who received rocuronium–sugammadex (RS group) or cisatracurium/atracurium–pyridostigmine (CP group) between 2020 and 2021 at three tertiary referral hospitals were included. Propensity score-matching was performed using a logistic regression model. The primary outcomes were safety-related indicators (e.g., reintubation, deferred extubation, and desaturation). Secondary outcomes included recovery-related profiles (e.g., extubation time). Subgroup analyses were conducted according to the CKD stage.
Results
Of the total 1,241 patients (RS = 630, CP = 611), 804 (402 per group) were matched and analyzed. Among them, 51.1% had advanced CKD (estimated glomerular filtration rate < 30 ml/min/1.73 m2). Primary safety outcomes, including the incidence of reintubation within 48 h (RS: 1.24% vs. CP: 1.24%, P = 1.000) and deferred extubation (1.74% vs. 1.49%, P = 0.780), were not significantly different. Postoperative desaturation and renal outcomes were similar between groups. Extubation time was shorter in the RS group than in the CP group (median 7.00vs. 8.00 min, P = 0.005).
Conclusions
Rocuronium–sugammadex demonstrated no clear signal of increased major respiratory or renal risk compared with cisatracurium/atracurium–pyridostigmine in patients with CKD. Although the extubation time was shorter in the RS group, this exploratory finding must be interpreted cautiously because of the heterogeneous practice and limited quantitative neuromuscular monitoring (22%).
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Anesthesiology and Pain Medicine, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Korea.
- Department of Anesthesiology and Pain Medicine, Korea University Ansan Hospital, Korea University College of Medicine, Ansan, Korea.
- Department of Anesthesiology and Pain Medicine, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Korea.
Zitieren
APA
Lee, D., Oh, S. K., Kim, H., Jeong, S., Choi, E. S., Ko, E. J., & Lim, B. G. (2026). Safety and recovery of rocuronium and sugammadex versus cisatracurium or atracurium and pyridostigmine in surgical patients with chronic kidney disease: a multicenter retrospective propensity score-matched study. Anesthesia and Pain Medicine, 21(4), 553-566. https://doi.org/10.17085/apm.25496
Vancouver
Lee D, Oh SK, Kim H, Jeong S, Choi ES, Ko EJ, et al. Safety and recovery of rocuronium and sugammadex versus cisatracurium or atracurium and pyridostigmine in surgical patients with chronic kidney disease: a multicenter retrospective propensity score-matched study. Anesthesia and Pain Medicine. 2026;21(4):553-566. doi:10.17085/apm.25496
BibTeX
@article{Lee2026,
author = {Lee, Doyeop and Oh, Seok Kyeong and Kim, Heezoo and Jeong, Seokwoo and Choi, Eun-Su and Ko, Eun Ji and Lim, Byung Gun},
title = {Safety and recovery of rocuronium and sugammadex versus cisatracurium or atracurium and pyridostigmine in surgical patients with chronic kidney disease: a multicenter retrospective propensity score-matched study},
journal = {Anesthesia and Pain Medicine},
year = {2026},
volume = {21},
number = {4},
pages = {553--566},
doi = {10.17085/apm.25496}
}
EUVIMED